Eliem press releases
WebMar 7, 2024 · This press release contains forward-looking statements, including, without limitation, statements relating to: the continued development and clinical and therapeutic potential ETX-155 and ETX-810 ... WebJul 18, 2024 · This press release contains forward-looking statements, including, without limitation, statements relating to: the continued development and clinical and therapeutic potential ETX-155, ETX-810 and Eliem’s Kv7 channel opener program; Eliem’s belief regarding the likely cause of a lower-than-expected exposure observed in the referenced …
Eliem press releases
Did you know?
WebFind the latest Eliem Therapeutics, Inc. (ELYM) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Press Releases. Research Reports. WebOct 5, 2024 · SEATTLE and CAMBRIDGE, United Kingdom, Oct. 05, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology …
WebMar 7, 2024 · SEATTLE and CAMBRIDGE, UK, -- (GLOBE NEWSWIRE) - March 6, 2024 - Eliem Therapeutics, Inc. (Nasdaq: ELYM), a biotechnology company focused on … WebGet the latest Eliem Therapeutics, Inc. (ELYM) stock news and headlines to help you in your trading and investing decisions.
WebAug 13, 2024 · Eliem Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares. SEATTLE … WebJun 27, 2024 · Eliem expressly disclaims any duty, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Eliem's ...
WebOct 5, 2024 · SEATTLE and CAMBRIDGE, United Kingdom, Oct. 05, 2024 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. ( Nasdaq: ELYM ), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the …
WebAug 10, 2024 · SEATTLE and CAMBRIDGE, United Kingdom, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc., a clinical-stage biotechnology company … trivium wineWebMar 6, 2024 · The forward-looking statements made in this press release speak only as of the date of this press release. Eliem expressly disclaims any duty, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Eliem's expectations with regard thereto or any change ... trivium work shirtWebApr 13, 2024 · Press Releases Chinook Therapeutics Announces the Appointment of Robert W. Azelby to its Board of Directors ... Most recently, he served as president and chief executive officer of Eliem Therapeutics, a biotechnology company focused on developing novel therapies for neurology disorders, where he led the company through early growth … trivium world goes coldWebMay 3, 2024 · On this news, Eliem's stock price fell $3.63 per share, or 55.76% percent, to close at $2.88 per share on April 25, ... More news releases in similar topics. Banking & Financial Services; trivium what the dead men say cdWebFeb 9, 2024 · Eliem Therapeutics, Inc., a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, … trivium world so coldWebMar 20, 2024 · Get the latest news and real-time alerts from Eliem Therapeutics, Inc. (ELYM) stock at Seeking Alpha. Eliem Therapeutics, Inc. (ELYM) Latest Stock News … trivium worldWebMar 7, 2024 · SEATTLE and CAMBRIDGE, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company focused on developing novel therapies for... trivium world goes cold lyrics